| Richard J Hicks, MD | |
|
759 Chestnut St, Radiology Department, Springfield, MA 01107-1619 | |
| (413) 827-7426 | |
| (413) 827-7407 |
| Full Name | Richard J Hicks |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 43 Years |
| Location | 759 Chestnut St, Springfield, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245264308 | NPI | - | NPPES |
| 3022803 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 056979 (Massachusetts) | Primary |
| 2085R0202X | Radiology - Diagnostic Radiology | 035720 (Connecticut) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baystate Medical Center | Springfield, MA | Hospital |
| Baystate Noble Hospital | Westfield, MA | Hospital |
| Baystate Franklin Medical Center | Greenfield, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baystate Medical Practices Inc | 5991602971 | 1015 |
| Radiology And Imaging Inc | 9234110479 | 50 |
News Archive
Three phase III studies being presented at the European Committee for Treatment Research in Multiple Sclerosis congress demonstrate that treating MS with ocrelizumab reduces relapse rate and delay onset of disability progression compared to interferon beta-1a in relapsing forms of MS and disability progression in primary progressive MS compared to placebo.
A recent study conducted by a research team around Hilke Plassmann, the INSEAD Chaired Professor of Decision Neuroscience & Brain and Spine Institute, a principal investigator in the Social Affective Neuroscience Team at the ICM, David Dubois, Associate Professor of Marketing at INSEAD and Gideon Nave, Assistant Professor of Marketing at The Wharton School & the Wharton Neuroscience Initiative shows that testosterone, the male sex hormone, increased men's preference for status goods compared to goods of similar perceived quality but seen as lower in status.
Breast imaging reports generated using an automatic speech recognition system are nearly six times more likely to contain major errors than those generated with conventional dictation transcription, a new study in Canada shows.
St. Jude Medical, Inc. has announced U.S. Food and Drug Administration (FDA) and European CE Mark approval of the Angio-Seal Evolution Vascular Closure Device. The approval and global launch was announced at the Transcatheter Cardiovascular Therapeutics conference in Washington, D.C.
Los Angeles Association of Health Underwriters announces its annual Health Insurance Awareness Week. This week is set aside to perform outreach to the community in the form of health awareness and to the importance of the role of the health insurance agent.
› Verified 5 days ago
| Entity Name | Baystate Medical Practices Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548205909 PECOS PAC ID: 5991602971 Enrollment ID: O20040225000080 |
News Archive
Three phase III studies being presented at the European Committee for Treatment Research in Multiple Sclerosis congress demonstrate that treating MS with ocrelizumab reduces relapse rate and delay onset of disability progression compared to interferon beta-1a in relapsing forms of MS and disability progression in primary progressive MS compared to placebo.
A recent study conducted by a research team around Hilke Plassmann, the INSEAD Chaired Professor of Decision Neuroscience & Brain and Spine Institute, a principal investigator in the Social Affective Neuroscience Team at the ICM, David Dubois, Associate Professor of Marketing at INSEAD and Gideon Nave, Assistant Professor of Marketing at The Wharton School & the Wharton Neuroscience Initiative shows that testosterone, the male sex hormone, increased men's preference for status goods compared to goods of similar perceived quality but seen as lower in status.
Breast imaging reports generated using an automatic speech recognition system are nearly six times more likely to contain major errors than those generated with conventional dictation transcription, a new study in Canada shows.
St. Jude Medical, Inc. has announced U.S. Food and Drug Administration (FDA) and European CE Mark approval of the Angio-Seal Evolution Vascular Closure Device. The approval and global launch was announced at the Transcatheter Cardiovascular Therapeutics conference in Washington, D.C.
Los Angeles Association of Health Underwriters announces its annual Health Insurance Awareness Week. This week is set aside to perform outreach to the community in the form of health awareness and to the importance of the role of the health insurance agent.
› Verified 5 days ago
| Entity Name | Radiology & Imaging Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790731008 PECOS PAC ID: 9234110479 Enrollment ID: O20060418000566 |
News Archive
Three phase III studies being presented at the European Committee for Treatment Research in Multiple Sclerosis congress demonstrate that treating MS with ocrelizumab reduces relapse rate and delay onset of disability progression compared to interferon beta-1a in relapsing forms of MS and disability progression in primary progressive MS compared to placebo.
A recent study conducted by a research team around Hilke Plassmann, the INSEAD Chaired Professor of Decision Neuroscience & Brain and Spine Institute, a principal investigator in the Social Affective Neuroscience Team at the ICM, David Dubois, Associate Professor of Marketing at INSEAD and Gideon Nave, Assistant Professor of Marketing at The Wharton School & the Wharton Neuroscience Initiative shows that testosterone, the male sex hormone, increased men's preference for status goods compared to goods of similar perceived quality but seen as lower in status.
Breast imaging reports generated using an automatic speech recognition system are nearly six times more likely to contain major errors than those generated with conventional dictation transcription, a new study in Canada shows.
St. Jude Medical, Inc. has announced U.S. Food and Drug Administration (FDA) and European CE Mark approval of the Angio-Seal Evolution Vascular Closure Device. The approval and global launch was announced at the Transcatheter Cardiovascular Therapeutics conference in Washington, D.C.
Los Angeles Association of Health Underwriters announces its annual Health Insurance Awareness Week. This week is set aside to perform outreach to the community in the form of health awareness and to the importance of the role of the health insurance agent.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard J Hicks, MD 780 Chestnut St, Springfield, MA 01107-1610 Ph: (413) 827-7426 | Richard J Hicks, MD 759 Chestnut St, Radiology Department, Springfield, MA 01107-1619 Ph: (413) 827-7426 |
News Archive
Three phase III studies being presented at the European Committee for Treatment Research in Multiple Sclerosis congress demonstrate that treating MS with ocrelizumab reduces relapse rate and delay onset of disability progression compared to interferon beta-1a in relapsing forms of MS and disability progression in primary progressive MS compared to placebo.
A recent study conducted by a research team around Hilke Plassmann, the INSEAD Chaired Professor of Decision Neuroscience & Brain and Spine Institute, a principal investigator in the Social Affective Neuroscience Team at the ICM, David Dubois, Associate Professor of Marketing at INSEAD and Gideon Nave, Assistant Professor of Marketing at The Wharton School & the Wharton Neuroscience Initiative shows that testosterone, the male sex hormone, increased men's preference for status goods compared to goods of similar perceived quality but seen as lower in status.
Breast imaging reports generated using an automatic speech recognition system are nearly six times more likely to contain major errors than those generated with conventional dictation transcription, a new study in Canada shows.
St. Jude Medical, Inc. has announced U.S. Food and Drug Administration (FDA) and European CE Mark approval of the Angio-Seal Evolution Vascular Closure Device. The approval and global launch was announced at the Transcatheter Cardiovascular Therapeutics conference in Washington, D.C.
Los Angeles Association of Health Underwriters announces its annual Health Insurance Awareness Week. This week is set aside to perform outreach to the community in the form of health awareness and to the importance of the role of the health insurance agent.
› Verified 5 days ago
Laurie E Gianturco, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1350 Main St Ste 1007, Springfield, MA 01103 Phone: 413-827-7400 Fax: 413-827-7407 | |
Linda Esther Bornstein, MD Radiology Medicare: Medicare Enrolled Practice Location: 3350 Main St, Springfield, MA 01107 Phone: 413-794-9175 Fax: 413-794-5153 | |
Christopher Badalucco, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 759 Chestnut St, Springfield, MA 01107 Phone: 413-827-7400 | |
Christopher C Moore, MD, PH.D Radiology Medicare: Accepting Medicare Assignments Practice Location: 759 Chestnut St, Radiology Department, Springfield, MA 01107 Phone: 413-827-7426 Fax: 413-827-7407 | |
Dr. Thomas Joseph Anderson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1350 Main St Ste 1007, Springfield, MA 01103 Phone: 413-827-7400 | |
Dr. Jason L. Port, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3640 Main St, Suite 101, Springfield, MA 01107 Phone: 413-781-9000 Fax: 413-781-7988 | |
Michael E. Swirsky, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 759 Chestnut St, Radiology Department, Springfield, MA 01107 Phone: 413-827-7426 Fax: 413-827-7407 |